Dr. Evrim Metcalfe

About Dr. Evrim Metcalfe

Dr. Evrim Metcalfe is a highly esteemed radiation oncologist renowned for her extensive and illustrious career.
She earned her solid medical foundation from Dokuz Eylül University and pursued a specialization in radiation oncology at Ege University.
Her professional journey began in 2006 at Samsun Education and Research Hospital, where she fulfilled her initial training obligations and swiftly established herself as a dedicated specialist in the field.
She has held several important positions throughout the years, such as Clinical Supervisor at Neolife Medical Center and later at Medicana International Istanbul Hospital, where she substantially contributed to clinical education and patient care.
Dr. Evrim Metcalfe’s academic accomplishments are similarly remarkable; she has held positions as an associate professor and lecturer at universities including Feyziye Schools Foundation Işık University and Eskişehir Osmangazi University.
She became a Professor in the Department of Radiation Oncology at Biruni University Faculty of Medicine in 2022, contributing her vast knowledge and experience to clinical and academic contexts.
Radiation oncologist Dr. Evrim Metcalfe is well-respected for her dedication to improving patient care and education and her many contributions.

Conditions treated by Dr. Evrim Metcalfe

Acoustic neuroma
Acute lymphocytic leukemia
Adnexal tumors
Adrenal cancer
Ameloblastoma
Ampullary cancer
Anal cancer
Bladder cancer
Bone cancer
Brain tumor
Breast cancer
Cancer
Carcinoma of unknown primary
Cervical cancer
Cholangiocarcinoma (bile duct cancer)
Chondrosarcoma
Chordoma
Colon cancer
Craniopharyngioma
Cushing syndrome
Cutaneous T-cell lymphoma
Desmoid tumors
Desmoplastic small round cell tumors
Ductal carcinoma in situ (DCIS)
Endometrial cancer
Esophageal cancer
Esthesioneuroblastoma
Ewing sarcoma

Area of Interest

Radioiodine therapy
Radiosurgery for brain tumors, colorectal cancer, prostate cancer, breast cancer, cervical cancer, testicular cancer, and Stereotaxic radiosurgery
Therapy with radioactive iodine in thyroid cancer
Radiotherapy for throat cancer, lung cancer, uterine cancer, stomach cancer, kidney cancer, and bowel cancer
Radioembolization for liver cancer
Xofigo Radium-223MRI of one area
PET/CT (computer tomography)
Tumor Marker Blood Test
MammographyCT scan of the whole body
CT of thoracic, abdominal, and pelvic organs
PET-CT with Gallium 68(PSMA)MRI of the abdominal cavity
Brain MRI with contrast (FLAIR sequence)
PET-CT with Gallium 68 (DOTA)
KRAS, NRAS, BRAF mutation testing.

Qualification

2022, Biruni University Faculty of Medicine, Department of Radiation Oncology, Faculty Member, Professor Doctor.
2022, Anadolu University Open Education Faculty Undergraduate Program, Cultural Heritage and Tourism.
2021, Feyziye Schools Foundation Işık University Health Services Vocational School, Faculty Member, Associate Professor Doctor.
2017, Eskişehir Osmangazi University Faculty of Medicine, Department of Radiation Oncology, Lecturer.
2017, Eskişehir Osmangazi University Faculty of Medicine, Department of Radiation Oncology, Associate Professor.
2006, Samsun Education and Research Hospital, Specialist Doctor, Compulsory Service.
2006, Dokuz Eylul University Faculty of Medicine, Department of Radiation Oncology, Medical Specialization.
1998, Ege University, Faculty of Medicine

Global Team of Board Certified Surgeons and Medical Specialists
Written Second Opinion report delivered within 5 days
Option to avail the Video Consultation with the Lead Doctor of the board

Access Our most trusted Medical Second Opinion

Telemedicine Doctors

Do you know?

You can book a video consultation with Dr. Evrim Metcalfe on our platform

Consult Online

MEMBERSHIPS (1)

Turkish Medical Association

RESEARCH PAPERS AND PUBLICATIONS (12)

Gorken IB, Bayman E, Balci P, Bakis B, Karaguler Z, Isman BD, Kinay M. Comparing ultrasound with computerized tomography images to choose electron energy for radiotherapy boost field in breast cancer patients with breast-conserving surgery. JBUON 2010; 15 (3): 500-503.
Eliz D, Bayman E, Akcay M, Sahin B, Bal C. Dosimetric and clinical predictors of acute esophagitis in lung cancer patients in Turkey treated with radiotherapy. Asian Pac J Cancer Prev 2013; 14(7): 4223-4228.
Erpolat OP, Alco G, Caglar HB, Igdem S, Saran A, Dagoglu N, Aslay I, Ozsaran Z, Demirci S, Keven E, Guney Y, Akmansu M, Kilic D, Bayman E, Etiz D, Mandel NM. Comparisonofhematologictoxicitybetween3DCRTandIMRTplanningincervicalcancerpatientsafter concurrent chemoradiotherapy: a national multi-center study. Eur J Gynaecol Oncol2014; 35(1): 62-6.
Bayman E, Prestwich RJ, Speight R, Aspin L, Garratt L, Wilson S, Dyker KE, Sen M. Patterns of Failure after Intensity-modulated Radiotherapy in Head and Neck Squamous Cell Carcinoma Using Compartmental Clinical Target Volume Delineation. Clin Oncol (R Coll Radiol) 2014; 26(10): 636-42.
Bayman E, Etiz D, Akcay M, Ak G. Timing of Thoracic Radiotherapy in Limited Stage Small Cell Lung Cancer: Results of Early Versus Late Irradiation from a Single Institution in Turkey. Asian Pac J Cancer Prev 2014; 15(15): 6264-7.
Murray L, Sethugavalar B, Robertshaw H, Bayman E, Thomas E, Gilson D, Prestwich RJ. Involved Node, Site, Field, and Residual Volume Radiotherapy for Lymphoma: A Comparison of Organ at Risk Dosimetry and Second Malignancy Risks. Clin Oncol (R Coll Radiol)2015;27(7):401-10.
Bird D, Scarsbrook AF, Sykes J, Ramasamy S, Subesinghe M, Carey B, Wilson DJ, Roberts N, McDermott G, Karakaya E, Bayman E, Sen M, Speight R, Prestwich RJ. Multimodality imaging with CT, MR, and FDG-PET for radiotherapy target volume delineation in oropharyngeal squamous cell carcinoma. BMC Cancer2015; 15:844.
Metcalfe E, Etiz D. Early transient radiation-induced brachial plexopathy in locally advanced head and neck cancer. Contemp Oncol (Pozn)2016; 20(1): 67-72.
Metcalfe E, Karaoglanoglu O, AkyaziciE. Radiotherapy with or without temozolomide in elderly patients aged ≥ 70 years with glioblastoma. Contemp Oncol (Pozn)2016; 20(3): 251-5.
Oktay E,Levent M,Gelincik H,Aktaş G,Yumuk F,Koral L,Arpacı E,Keser M,Alkan A,Karci E,Karadurmuş N,Degirmencioglu S,Turan M,Uyeturk U,Cabuk D,Avci N,Toprak O ,Ergen A,Urvay S,BaymanE,Petekkaya E,Nayir E,Paydaş S,Yavuzsen T,Senler FC,Yaren A,Barutca S,Şahinler İ,Ozyilkan O,TanriverdiO. Perspective of Turkish Medicine Students on Cancer, Cancer Treatments, Palliative Care, and Oncologists (ARES Study): a Study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG). J Cancer Educ2020; 35(1): 69-75.
Gorken IB, Bayman E, Balci P, Bakis B, Kocdor MA, Karaguler Z, Isman BD, Cetinayak O, Alanyali H, Kinay M. Comparing ultrasound (US) with computerized tomography (CT) images to choose electron energy for boost field in breast cancer patients with breast-conserving surgery (Verbal). 6th Congress BUON, Sofia, Bulgaria, September 13-16, 2006.
Bıçakcı N, Bayman E. PET-CT negative osteoblastic bone metastasis progression in a patient under follow-up with a diagnosis of metastatic breast cancer: Case Report (Poster). 9th International Nuclear Oncology Congress & 22nd National Nuclear Medicine Congress, 25-29 April 2010, Antalya.

Share Your Experience about Dr. Evrim Metcalfe

Write Your Review

PROCEDURES

Radiation Therapy

FREQUENTLY ASKED QUESTIONS

Q: Is Doctor Evrim Metcalfe doing teleconsultation on the MediGence platform?

A. Dr. Evrim Metcalfe is available to teleconsultate on the MediGence platform.

Q: How long is the consultation?

A. The consultation can last up to 15 to 30 minutes. It may go beyond the estimated time which is dependent on the patient’s queries and the medical suggestions of the doctor.

Q: How soon can the consultation be organized?

A. We have Medical specialists and board-certified doctors on our panel of doctors. The consultation will be organized within 24 to 48 hours or based on the availability of the doctor and the patient.

Q: Is follow-up consultation included in the consultation price?

A. No, the follow-up consultation fee is not included in the consultation price. The patient will be required to re-book the consultation.

Q: How do I share my medical record with the doctor for review?

A. The option to share your medical records is available between the steps of the form provided to you on the website.

Q: Can I book my procedure with the doctor post-consultation?

A. Yes. If you are satisfied with the consultation, then you can go ahead with treatment packages for your diagnosis with the help of our case managers.

Q: Is it possible to get the estimate for the procedure?

A. Yes. The cost estimate will be provided to you by our case manager including the doctor’s opinion, the cost estimate, and the crucial information about traveling to your medical destination.

Welcome To MediGence

Your Notifications

1+

1